Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Hepatitis C, Chronic 1 Carcinoma, Hepatocellular 1

Interventions

Capecitabine 5 Bevacizumab 5 Radiotherapy 3 Oxaliplatin 3 toripalimab 2 olaparib 2 durvalumab 2 darolutamide 2 dalpiciclib 2 atezolizumab 2 apatinib 2 anlotinib 2 Surgical Procedures, Operative 2 Standard of Care 2 Radiosurgery 2 Leucovorin 2 Laparoscopy 2 Immunotherapy 2 Fluorouracil 2 Drug Therapy 2 130-nm albumin-bound paclitaxel 2 trametinib 1 tislelizumab 1 spartalizumab 1 pyrotinib 1 pomalidomide 1 palbociclib 1 nilotinib 1 ledipasvir, sofosbuvir drug combination 1 ledipasvir 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Simeprevir × 90 days × Clear all

NCT02771405 2026-04-13

FRI-STC

National Hepatology & Tropical Medicine Research Institute

Phase 3 Completed

Gastrointestinal

Carcinoma, Hepatocellular, Hepatitis C, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡